Jul 2026
SLFN11 binds DDX1 to counteract human mesenchymal stem/stromal cell senescence through inhibition of mTOR/eIF4E signaling pathway activation.
A non-canonical role for SLFN11 safeguarding MSCs from senescence via the DDX1/mTOR/eIF4E axis is delineated and SLFN11-overexpressing MSCs constitute a promising and safe cell therapy source, characterized by preserved pluripotency and augmented therapeutic efficacy.
Xin-Xin Zhu, Yi Luo, Jin-Yan Xu et al.
· Life Science · 0 citations